Oncologics, lipid regulators, respiratory agents, antidiabetics and anti-ulcerants are the five largest drug classes by sales. But annual sales are only half the story. Which drug classes are booming, and which have plateaued–or even dropped? IMS Health has released top-line industry data revealing the 15 largest drug classes, and we’ve crunched the numbers to take a closer [...]
In the quest for a cancer vaccine, Merck KGaA is again stepping into the ring. Vaximm Holding AG, the company’s joint venture with a Switzerland’s BB Biotech Ventures III, will start testing a therapeutic cancer vaccine in patients next year. The vaccine, VXM01, harnesses the body’s immune system to fight cancer by using T-cells to close off [...]
Children with the most common childhood cancer did not experience improved outcomes from participating in a clinical trial between 1997 and 2005.
Knowing the stage of a patient’s melanoma is important when choosing the best course of treatment. When the cancer has progressed to the lymph nodes, a more aggressive treatment is needed. Examining an entire lymph node for cancer takes much effort and time. Now, a new technique might help make the process more efficient.
Using lasers and nanoparticles, scientists at Rice University have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers to make “nanobubbles” by zapping gold nanoparticles inside cells. In tests on cancer cells, they found they could tune the lasers to create either small, bright [...]
New research, which poses some serious implications on women’s health, is seeking to explain why women develop breast cancer and how they may prevent breast cancer and keep it from recurring. The findings from this new study show that hormonal balance is the best determiner of whether or not a malignant growth in a woman’s [...]
As recently as 1950, lymphoma was almost inevitably fatal but these days up to 90 per cent of those newly diagnosed with Hodgkin’s lymphoma can expect to be cured. Non-Hodgkin’s is less easily treated, with an overall cure rate of about 60 per cent.
The Epstein-Barr Virus (EBV), also called Human herpes virus 4 (HHV-4), is a virus of the herpes family (which includes Herpes simplex virus), and is one of the most common viruses in humans. Most people become infected with EBV, which is often asymptomatic but commonly causes infectious mononucleosis.
Lymphoma is a group of neoplasms that derive from immune cells residing in the lymph system. The nosology used to differentiate these neoplasms has evolved hand-in-hand with the evolution of the understanding of the immune system and its malignancies. The key distinctions between types of lymphoma are based on cell type and rate of growth. [...]
Non-Hodgkin’s lymphoma is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin’s lymphoma, tumors develop from white blood cells (lymphocytes). These tumors can occur at different locations in your body. There are more than 30 types of non-Hodgkin’s lymphoma.
You are currently browsing the weblog archives for 'lymphoma' tag.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.
Biotech Trading Signals Pharma News Biotech News